Aspira Pathlab & Diagnostics Ltd (540788) — Board Meeting | 31 August 2026(2 announcements)

Aspira Pathlab & Diagnostics announced that its 53rd Annual General Meeting will be held on September 25, 2026 via video conference, with book closure running from September 19 to September 25, 2026, during which shareholders cannot trade shares; e-voting remains open from September 22 to 24, 2026, and the meeting will follow MCA and SEBI e-voting guidelines.

Aspira Pathlab & Diagnostics Ltd convened its 53rd Annual General Meeting on September 25, 2026, via video conferencing, reappointing Mr. Nikunj Velji Mange as Managing Director with a fixed remuneration of ₹48 lakhs and performance incentive up to ₹48 lakhs, while appointing Mr. Vaibhav Odhekar as Executive Director at ₹36 lakhs fixed plus ₹36 lakhs incentive. The meeting addressed key resolutions including director reappointments, related party transaction approvals for Yashraj Research Foundation services valued at ₹5 crores (22.72% of consolidated turnover), and executive director appointments, with voting conducted electronically through NSDL during September 22–24, 2026. Shareholders must confirm eligibility by September 18, 2026, and participate via NSDL login using DP ID, PAN, or beneficiary ID, with proxy attendance restricted to authorized representatives. The filing confirms full compliance with regulatory norms, no material uncertainties, and no defaults, while highlighting financial volatility with net profit declining to ₹5.13 lakhs (from ₹207.26 lakhs) and revenue growth moderating to ₹2,498.20 lakhs, alongside significant drops in return on equity to 0.42% and current ratio to 1.47.